These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15257859)

  • 1. Are angiotensin receptor blockers neuroprotective?
    Thöne-Reineke C; Zimmermann M; Neumann C; Krikov M; Li J; Gerova N; Unger T
    Curr Hypertens Rep; 2004 Aug; 6(4):257-66. PubMed ID: 15257859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G; Amiri F; Garcia R
    Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor pharmacology and AT1-receptor blockers.
    Chung O; Csikós T; Unger T
    J Hum Hypertens; 1999 Jan; 13 Suppl 1():S11-20; discussion S33-4. PubMed ID: 10076916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection with angiotensin receptor antagonists: a review of the evidence and potential mechanisms.
    Wilms H; Rosenstiel P; Unger T; Deuschl G; Lucius R
    Am J Cardiovasc Drugs; 2005; 5(4):245-53. PubMed ID: 15984907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting renin-angiotensin in the brain: the possible therapeutic implications.
    Unger T
    Blood Press Suppl; 2001; 1():12-6. PubMed ID: 11333008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AT1 receptor blockade in experimental myocardial ischemia/reperfusion.
    Jalowy A; Schulz R; Heusch G
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S129-36. PubMed ID: 9892153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking the tissue renin-angiotensin system: the future cornerstone of therapy.
    Unger T; Azizi M; Belz GG
    J Hum Hypertens; 2000 Oct; 14 Suppl 2():S23-31. PubMed ID: 11086633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
    Babiker F; Al-Jarallah A; Joseph S
    PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor blockers.
    Burnier M
    Circulation; 2001 Feb; 103(6):904-12. PubMed ID: 11171802
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
    Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
    Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
    Brilla CG; Scheer C; Rupp H
    J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin receptors: physiology and pharmacology.
    Guthrie GP
    Clin Cardiol; 1995 Jun; 18(6 Suppl 3):III 29-34. PubMed ID: 7634561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
    Kim S; Iwao H
    J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
    Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
    Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB; Smith RD
    Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.